Pros
Remote monitoring for for cardiac arrhythmia devices is in high demand and the company Geneva who was bought by Biotelemetry and since sold to Phillips had a great vision on getting this accomplished for a broad spectrum of patients across the United States.
Kontras
Inconsistent training, database crashed several times a week sometimes more than once in a day, hub lead support was poor-asking for help to understand the inconsistent various answers from super users was a burden for them to deal with, certain hubs had very high turn over due to poor attitudes. Coordinators did not work on first in first out basis after alerts were done. The early folks in the EST will come on and weed out all the quick easy reads to meet quotas or you had to get up and on before those employees, no matter your time zone, so you were not left with only the time consuming patients to read making for very long days to meet your own quotas. Poor organization and IT issues with the database.